SpaceX's $1 Trillion Wipeout Tests the IPO Machine as Jersey Mike's and Reformation Step Up

Six weeks ago, SpaceX completed the largest initial public offering in history, raising roughly $86 billion at $135 a share^[1]. The stock rocketed to a peak market capitalization near $2.67 trillion before gravity reasserted itself^[2]. As of July 29, SPCX trades at $113.79 — down 15.7% from its IPO price and 20% below its debut day close^[3]. More than $1.2 trillion in market value has evaporated from the peak^[2]. Roughly 185 million shares are now sold short, representing about 29% of the publicly tradable float, and short sellers are sitting on an estimated $8.7 billion in paper profits^[2].

That is the backdrop against which this week’s IPO calendar arrives. The question is no longer whether the IPO window is open — it clearly is, and wide. The question is what happens when the deals coming through that window are not rockets or AI chipmakers but sandwich shops and fashion brands.

This Week’s IPO Calendar

Source: StockAnalysis.com IPO calendar, SEC filings^[1]

The calendar is a mix tape of 2026’s competing narratives. A rare-earths miner, a blank-check SPAC, a sandwich chain, a fashion retailer, a sleep-apnea drug developer, and a ticketing platform — all priced within four trading days. The two marquee names, Jersey Mike’s and Reformation, are the ones that tell us the most about market appetite.

Consumer Brands Take the Stage

Jersey Mike’s Subs, backed by Blackstone, is aiming to raise up to $1.09 billion at the top of its $21–$25 range, which would produce an initial market capitalization approaching $8 billion^[2]. The chain generated $742 million in revenue, according to its filing^[1]. Reuters noted that U.S. retail listing volumes this year are the lowest in a decade, making Jersey Mike’s a genuine stress test for the consumer-IPO thesis^[2].

Reformation, the Permira-backed womenswear brand, is targeting a valuation of up to $1 billion with a $225 million raise at $15–$17 per share^[2]. The company reported $533 million in revenue^[1]. A fashion IPO at a ~$1 billion valuation is a rare bird in 2026 — the pipeline has been overwhelmingly dominated by AI and space-tech companies.

The base-rate question: in a year where the median non-SPAC IPO is trading below its offer price (Standard Nuclear cut its deal by more than half and still sits 52% underwater; Fervo Energy is down 32%; ERock has lost 53%)^[3], how much tolerance remains for consumer-growth stories without an AI narrative attached?

My read: 60/40 that Jersey Mike’s prices within its range and trades flat to modestly positive in the first week. The $8 billion valuation is full for a $742 million revenue sandwich chain — that is roughly 10.8x sales — but the franchise model, Blackstone’s expense optimization, and the scarcity value of a consumer IPO in a tech-saturated year provide a floor. The 40% case involves a break below the $21 low end if broader risk-off sentiment from the Fed decision and oil spike spills into new-issue demand.

The AI IPO Conveyor Belt

The AI IPO pipeline remains the dominant force in market structure. Several developments converged in the past two weeks:

• SK Hynix raised $26.5 billion in its U.S. listing on July 10 — the largest foreign IPO in U.S. history^[2]. Shares debuted at $149 and now trade at $126.42, down 12.5%^[3]. Nasdaq President Nelson Griggs said the listing is already attracting more foreign companies to consider U.S. listings^[2].

• Csquare, a Brookfield-backed data center operator with 64 sites, priced at $21 on July 16 and is essentially flat at $20.84^[3]. The deal was framed as a test of whether investors still have appetite for AI infrastructure after the SpaceX and SK Hynix corrections^[2].

• Anthropic is scheduling investor meetings ahead of a potential IPO as soon as October, with Goldman Sachs, Morgan Stanley, and JPMorgan leading the offering^[2]. The company is also arranging credit lines worth billions of dollars and is reportedly considering mandatory employee stock trading plans post-IPO to avoid insider-trading concerns^[2].

• OpenAI continues preparations, adding two independent board members (David Vélez of Nubank and Robin Vince of BNY) and consolidating power under co-founder Greg Brockman^[2]. However, Apple’s trade-secrets lawsuit against OpenAI has been flagged as a potential disruption to its IPO timeline^[2].

• CXMT, China’s memory chip manufacturer, raised $8.6 billion in Shanghai — Asia’s biggest IPO this year — and surged 466% on its first day, rattling global chip stocks^[2].

The pattern is clear: deal volume is accelerating, but post-IPO performance is bifurcating. AI-adjacent names with proven revenue (Cerebras at +4.2%, Bending Spoons at +12.7%) are holding^[3]. Pure-play infrastructure and speculative AI names are getting repriced hard. SpaceX is the extreme case, but SK Hynix’s 12.5% decline and Quantinuum’s 21.4% drop tell the same story^[3].

Market-Structure Watch: Onchain IPOs, Lockups, and Short Selling

Several plumbing-level developments deserve attention:

Onchain offerings. Securitize and Cantor announced a collaboration to enable onchain IPOs and follow-on offerings for public companies, pairing Cantor’s equity capital markets expertise with Securitize’s regulated tokenization infrastructure^[2]. If this pipeline materializes, it represents a structural shift in how secondary offerings can be executed — potentially reducing settlement friction and expanding the investor base to onchain-native participants.

Employee lockup structures. Anthropic’s consideration of mandatory preset trading plans (10b5-1-style) for rank-and-file employees post-IPO is a notable departure from the standard 180-day lockup^[2]. If adopted, it would create a controlled-release mechanism rather than a cliff-date unlock — reducing the potential for lockup-expiration selling pressure but also dampening the liquidity event that employees may expect.

Short-selling concentration. SpaceX’s 29% short interest on its float is extraordinarily high for a newly public company^[2]. This creates a two-sided risk: a positive catalyst (successful Starship flight, earnings beat) could trigger a squeeze, while continued negative momentum feeds on itself. The Starship test flight on July 25 — the first since the IPO — was aborted due to engine issues^[2], which did not help.

Macro pressure on new issuance. The 10-year Treasury yield sits at 4.628%^[4], and brokerages are increasingly split on whether the Fed raises rates at this week’s meeting given surging oil prices (Brent at $90.01, up 7% on the day)^[4]. Rising risk-free rates compress the valuation case for growth IPOs. If the Fed delivers a hawkish surprise, expect IPO pricing to get defensive — smaller deal sizes, wider discounts, and more withdrawals.

IPO Performance Scorecard: 2026 Year-to-Date

Compiled from StockAnalysis.com recent IPO data^[3]

The data tells a sobering story: the median 2026 IPO is trading below its offer price. Biotech is the bright spot, driven by genuine clinical-readout catalysts (Hemab’s 162% gain, Parabilis’s 59.8% gain). Consumer and energy deals have the worst median outcomes. This is the environment Jersey Mike’s and Reformation are entering.

What to Watch Next

1. Jersey Mike’s and Reformation pricing (July 30). Whether both deals price within range and where they trade on day one will be the cleanest read on consumer-IPO demand. A break below the low end for either would signal that the window is narrowing for non-AI deals.

2. Fed decision (July 29–30). A hawkish surprise or even a hawkish hold with elevated oil prices could tighten risk appetite across the IPO complex. Watch the 10-year yield — a move above 4.70% would pressure growth-IPO valuations.

3. SpaceX short-interest dynamics. With 29% of float short, any positive catalyst — a successful Starship reflight, an unexpected contract announcement — could produce a violent squeeze. Conversely, continued drift toward $100 could trigger margin calls and forced selling.

4. Anthropic’s October timeline. If investor meetings go well and the macro backdrop stabilizes, Anthropic could be the next $50 billion-plus IPO. If SpaceX’s struggles spook the buy side, expect a delay into Q1 2027.

5. OpenAI’s Apple lawsuit exposure. The trade-secrets complaint from Apple adds a material overhang to OpenAI’s IPO preparations. Watch for settlement signals or escalation — both move the timeline.

6. Onchain IPO infrastructure adoption. The Securitize-Cantor partnership is early-stage, but the first real onchain follow-on offering by a public company would be a structural milestone worth tracking.

The IPO market in late July 2026 is a machine running at high speed with some parts vibrating loose. Deal volume is strong, the pipeline is deep, and the window is open. But the post-IPO performance record is deteriorating, the largest deal in history has become its most shorted stock, and the macro backdrop is tightening. The 60/40 read is that the window stays open through Q3 but narrows for anything without AI exposure or a hard clinical catalyst. For consumer brands and commodity plays, this week is the test.